Anti-inflammatory and hypolipidemic effects of the modified fatty acid tetradecylthioacetic acid in psoriasis – a pilot study

References

• Berge RK, Skorve J, Tronstad KJ, Berge K, Gudbrandsen OA, Grav H. Metabolic effects of thia fatty acids. Curr Opin Lipidol 2002;13:295–304.
   PubMed Web of Science ®Google Scholar
• Raspé E, Madsen L, Lefebvre AM, Leitersdorf I, Gelman L, Peinado-Onsurbe J, Dallongeville J, Fruchart JC, Berge R, Staels B. Modulation of rat liver apolipoprotein gene expression and serum lipid levels by tetradecylthioacetic acid (TTA) via PPARalpha activation. J Lipid Res 1999; 40:2099–110.
   PubMed Web of Science ®Google Scholar
• Dyroy E, Yndestad A, Ueland T, Halvorsen B, Damas JK, Aukrust P, Berge RK. Antiinflammatory effects of tetradecylthioacetic acid involve both peroxisome proliferator-activated receptor alpha-dependent and -independent pathways. Arterioscler Thromb Vasc Biol 2005;25:1364–9.
   PubMed Web of Science ®Google Scholar
• Muna ZA, Doudin K, Songstad J, Ulvik RJ, Berge RK. Tetradecylthioacetic acid inhibits the oxidative modification of low density lipoprotein and 8-hydroxydeoxyguanosine formation in vitro. Arterioscler Thromb Vasc Biol 1997;17: 3255–62.
   PubMed Web of Science ®Google Scholar
• Aukrust P, Wergedahl H, Müller F, Ueland T, Dyrøy E, Damås JK, Frøland SS, Berge RK. Immunomodulating effects of 3-thia fatty acids in activated peripheral blood mononuclear cells. Eur J Clin Invest 2003;33:426–33.
   PubMed Web of Science ®Google Scholar
• Fredriksen J, Ueland T, Dyrøy E, Halvorsen B, Melby K, Melbye L, Skalhegg BS, Bohov P, Skorve J, Berge RK, Aukrust P, Frøland SS. Lipid-lowering and anti-inflammatory effects of tetradecylthioacetic acid in HIV-infected patients on highly active antiretroviral therapy. Eur J Clin Invest 2004; 34:709–15.
   PubMed Web of Science ®Google Scholar
• Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueiredo A, Quintanilha A, Teixeira F. Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clin Chim Acta 2001;303:33–9.
   PubMed Web of Science ®Google Scholar
• Ikai K. Psoriasis and the arachidonic acid cascade. J Dermatol Sci 1999;21:135–46.
   PubMed Web of Science ®Google Scholar
• Vanizor KB, Orem A, Cimsit G, Yandi YE, Calapoglu M. Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis. Clin Chim Acta 2003;328:71–82.
   PubMed Web of Science ®Google Scholar
• Piskin S, Gurkok F, Ekuklu G, Senol M. Serum lipid levels in psoriasis. Yonsei Med J 2003;44:24–6.
   PubMed Web of Science ®Google Scholar
• Rocha-Pereira P, Santos-Silva A, Rebelo I, Figneiredo A, Quintanilha A, Teixeira F. Erythrocyte damage in mild and severe psoriasis. Br J Dermatol 2004;150:232–44.
   PubMed Web of Science ®Google Scholar
• Mallbris L, Akre O, Granath F, Yin L, Lindelof B, Ekbom A, Ståhle-Bäckdahl M. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 2004;19:225–30.
   PubMed Web of Science ®Google Scholar
• Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006;55:829–35.
   PubMed Web of Science ®Google Scholar
• Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA 2006;296:1735–41.
   PubMed Web of Science ®Google Scholar
• Cohen AD, Gilutz H, Henkin Y, Zahger D, Shapiro J, Bonneh DY, Vardy DA. Psoriasis and the metabolic syndrome. Acta Derm Venereol 2007;87:506–9.
   PubMed Web of Science ®Google Scholar
• Proksch E. [Antilipemic drug-induced skin manifestations]. Hautarzt 1995;46:76–80.
   PubMed Web of Science ®Google Scholar
• Jacobi TC, Highet A. A clinical dilemma while treating hypercholesterolaemia in psoriasis. Br J Dermatol 2003;149: 1305–6.
   PubMed Web of Science ®Google Scholar
• Gottlied AB, Chaudhari U, Baker DG, Perate M, Dooley LT. The National Psoriasis Foundation Psoriasis Score (NPF-PS) system versus the Psoriasis Area Severity Index (PASI) and Physician's Global Assessment (PGA): a comparison. J Drugs Dermatol 2003;2:260–6.
   PubMedGoogle Scholar
• Berge K, Tronstad KJ, Bohov P, Madsen L, Berge RK. Impact of mitochondrial beta-oxidation in fatty acid-mediated inhibition of glioma cell proliferation. J Lipid Res 2003;44:118–27.
   PubMed Web of Science ®Google Scholar
• Ludwig RJ, Herzog C, Rostock A, Ochsendorf FR, Zollner TM, Thaci D, Kaufmann R, Vogl TJ, Boehncke WH Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 2007;156:271–6.
   PubMed Web of Science ®Google Scholar
• Lee ML, To T, Nicholson E, Schrieber L. Endothelial cell adhesion molecules in psoriasis. Australas J Dermatol 1994; 35:65–70.
   PubMedGoogle Scholar
• Watabe D, Kanno H, Yoshida A, Kurose A, Akasaka T, Sawai T. Adhesion of peripheral blood mononuclear cells and CD4 + T cells from patients with psoriasis to cultured endothelial cells via the interaction between lymphocyte function-associated antigen type 1 and intercellular adhesion molecule 1. Br J Dermatol 2007Aug;157:259–65.
   PubMed Web of Science ®Google Scholar
• Ogilvie AL, Luftl M, Antoni C, Schuler G, Kalden JR, Lorenz HM. Leukocyte infiltration and mRNA expression of IL-20, IL-8 and TNF-R P60 in psoriatic skin is driven by TNF-alpha. Int J Immunopathol Pharmacol 2006;19:271–8.
   PubMed Web of Science ®Google Scholar
• Zalewska A, Glowacka E, Wyczolkowska J, Tchorzewski H, Narbutt J, Sysa-Jedrzejowska A. Interleukin 6 and 8 levels in plasma and fibroblast cultures in psoriasis. Mediators Inflamm 2006;2006:81767.
   PubMed Web of Science ®Google Scholar
• Schleyer V, Landthaler M, Szeimies RM. Novel pharmacological approaches in the treatment of psoriasis. J Eur Acad Dermatol Venereol 2005;19:1–20.
   PubMed Web of Science ®Google Scholar
• Wiedmann MW, Mössner J, Baerwald C, Pierer M. TNF alpha inhibition as treatment modality for certain rheumatologic and gastrointestinal diseases. Endocr Metab Immune Disord Drug Targets 2009;9:295–314.
   PubMedGoogle Scholar
• Parthasarathy S, Khoo JC, Miller E, Barnett J, Witztum JL, Steinberg D. Low density lipoprotein rich in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis. Proc Natl Acad Sci USA 1990; 87:3894–8.
   PubMed Web of Science ®Google Scholar